Published in Expert Rev Pharmacoecon Outcomes Res on April 01, 2011
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: (DCA/PDCD) | NCT02616484
Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology (2014) 1.85
Focus article: report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Eur Spine J (2014) 1.51
Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. Acta Orthop (2013) 1.18
Report of the NIH Task Force on research standards for chronic low back pain. J Pain (2014) 0.98
Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients. Med Decis Making (2011) 0.97
Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res (2014) 0.93
Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences. Qual Life Res (2013) 0.92
Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ Heart Fail (2013) 0.87
Report of the NIH Task Force on research standards for chronic low back pain. Phys Ther (2015) 0.87
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology (2015) 0.86
Quality of life and technology: impact on children and families with diabetes. Curr Diab Rep (2012) 0.85
Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C. Neurogastroenterol Motil (2013) 0.83
Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine. Am Health Drug Benefits (2012) 0.82
Development and validation of the PROcedural Sedation Assessment Survey (PROSAS) for assessment of procedural sedation quality. Gastrointest Endosc (2014) 0.82
Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia. Pain Ther (2013) 0.80
Thyroid-specific questions on work ability showed known-groups validity among Danes with thyroid diseases. Qual Life Res (2014) 0.78
Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial. Health Qual Life Outcomes (2015) 0.78
Best (but oft-forgotten) practices: expressing and interpreting associations and effect sizes in clinical outcome assessments. Am J Clin Nutr (2016) 0.78
Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab. Patient (2015) 0.77
Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases. J Pediatr Psychol (2015) 0.77
Report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Int J Ther Massage Bodywork (2015) 0.77
Decay of impact after self-management education for people with chronic illnesses: changes in anxiety and depression over one year. PLoS One (2013) 0.75
Minimal important improvement thresholds for the six-minute walk test in a knee arthroplasty cohort: triangulation of anchor- and distribution-based methods. BMC Musculoskelet Disord (2016) 0.75
A new health-related quality of life instrument for leukemia: will it be widely adopted soon? Drugs Context (2013) 0.75
Pragmatic Implementation of a Stratified Primary Care Model for Low Back Pain Management in Outpatient Physical Therapy Settings: Two-Phase, Sequential Preliminary Study. Phys Ther (2015) 0.75
Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes. PLoS One (2017) 0.75
Current Status of Celiac Disease Drug Development. Am J Gastroenterol (2016) 0.75
Prediction of pain outcomes in a randomized controlled trial of dose-response of spinal manipulation for the care of chronic low back pain. BMC Musculoskelet Disord (2015) 0.75
Interpreting small treatment differences from quality of life data in cancer trials: an alternative measure of treatment benefit and effect size for the EORTC-QLQ-C30. Health Qual Life Outcomes (2015) 0.75
Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience. Ther Adv Urol (2016) 0.75
Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges. Am Health Drug Benefits (2016) 0.75
A qualitative study of perceptions of meaningful change in spinal muscular atrophy. BMC Neurol (2017) 0.75
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes (2006) 26.32
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain (2001) 16.05
Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol (1994) 9.50
Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol (1999) 4.90
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes (2003) 3.42
Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD (2005) 2.85
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage (2006) 1.99
Evaluating the statistical significance of health-related quality-of-life change in individual patients. Eval Health Prof (2005) 1.27
Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire. Pharmacoeconomics (2003) 0.91
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol (2007) 6.24
The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Qual Life Res (2007) 4.61
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS) 2.0 adult core survey. Health Serv Res (2003) 4.24
Race/ethnicity, language, and patients' assessments of care in Medicaid managed care. Health Serv Res (2003) 4.19
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol (2010) 4.18
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care (2007) 3.56
Physician communication when prescribing new medications. Arch Intern Med (2006) 3.27
Do older adults expect to age successfully? The association between expectations regarding aging and beliefs regarding healthcare seeking among older adults. J Am Geriatr Soc (2002) 3.26
Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med (2004) 3.15
Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol (2005) 2.98
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.71
Patients' global ratings of their health care are not associated with the technical quality of their care. Ann Intern Med (2006) 2.68
A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol (2008) 2.67
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65
Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Rev Pharmacoecon Outcomes Res (2004) 2.58
Patient perspectives on the impact of fibromyalgia. Patient Educ Couns (2008) 2.57
Estimating clinically significant differences in quality of life outcomes. Qual Life Res (2005) 2.55
Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res (2009) 2.55
Patterns of unit and item nonresponse in the CAHPS Hospital Survey. Health Serv Res (2005) 2.49
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Development and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults. AIDS Behav (2008) 2.39
Linguistic disparities in health care access and health status among older adults. J Gen Intern Med (2006) 2.35
Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes (2007) 2.34
A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain (2008) 2.28
Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum (2008) 2.22
Methodological challenges associated with patient responses to follow-up longitudinal surveys regarding quality of care. Health Serv Res (2003) 2.21
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2010) 2.19
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
Exploratory factor analyses of the CAHPS Hospital Pilot Survey responses across and within medical, surgical, and obstetric services. Health Serv Res (2005) 2.15
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res (2009) 2.10
Psychometric properties of a group-level Consumer Assessment of Health Plans Study (CAHPS) instrument. Med Care (2005) 2.09
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology (2005) 2.07
What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health (2007) 2.06
Effect of a multidisciplinary intervention on communication and collaboration among physicians and nurses. Am J Crit Care (2005) 2.06
Severity of visual field loss and health-related quality of life. Am J Ophthalmol (2007) 2.05
Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis (2003) 2.05
Patients' preferences for technical versus interpersonal quality when selecting a primary care physician. Health Serv Res (2005) 2.01
Mode of administration is important in US national estimates of health-related quality of life. Med Care (2007) 2.00
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
Specialties differ in which aspects of doctor communication predict overall physician ratings. J Gen Intern Med (2013) 1.89
Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol (2009) 1.87
Health plan effects on patient assessments of Medicaid managed care among racial/ethnic minorities. J Gen Intern Med (2004) 1.86
Review of the literature on survey instruments used to collect data on hospital patients' perceptions of care. Health Serv Res (2005) 1.85
How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84
Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology (2006) 1.83
Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc (2004) 1.82
Methods used to streamline the CAHPS Hospital Survey. Health Serv Res (2005) 1.79
Equivalence of mail and telephone responses to the CAHPS Hospital Survey. Health Serv Res (2005) 1.77
Access to care for youth with special health care needs in the transition to adulthood. J Adolesc Health (2008) 1.73
Associations of presbyopia with vision-targeted health-related quality of life. Arch Ophthalmol (2003) 1.72
Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas (2007) 1.69
Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting. Qual Life Res (2011) 1.68
Psychometric properties of the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Clinician and Group Adult Visit Survey. Med Care (2012) 1.67
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol (2005) 1.66
Survey response style and differential use of CAHPS rating scales by Hispanics. Med Care (2008) 1.63
Effects of CAHPS health plan performance information on plan choices by New Jersey Medicaid beneficiaries. Health Serv Res (2002) 1.61
Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J Clin Epidemiol (2010) 1.61
Analysis of differential item functioning in the depression item bank from the Patient Reported Outcome Measurement Information System (PROMIS): An item response theory approach. Psychol Sci Q (2009) 1.56
Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol (2007) 1.54
An ethno-medical perspective on research participation: a qualitative pilot study. MedGenMed (2006) 1.53
The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved (2005) 1.53
Changes in symptoms and health-related quality of life in a nationally representative sample of adults in treatment for HIV. Qual Life Res (2006) 1.50
Development of and field test results for the CAHPS PCMH Survey. Med Care (2012) 1.47
Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc (2007) 1.43
Delays and unmet need for health care among adult primary care patients in a restructured urban public health system. Am J Public Health (2004) 1.43
Beyond alcoholism: identifying older, at-risk drinkers in primary care. J Stud Alcohol (2002) 1.42
A practical method to calibrate self-reported adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 1.42
Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol (2009) 1.42
IRT health outcomes data analysis project: an overview and summary. Qual Life Res (2007) 1.42
Health-related quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation. Am J Kidney Dis (2002) 1.42
Uncertainty and health-related quality of life 1 year after coronary angiography. Am J Crit Care (2008) 1.42
Depressed or not depressed: untangling symptoms of depression in patients hospitalized with coronary heart disease. Am J Crit Care (2014) 1.41
Adjusting for subgroup differences in extreme response tendency in ratings of health care: impact on disparity estimates. Health Serv Res (2008) 1.40
A randomized controlled study to evaluate the efficacy of noninvasive limb cover for chronic phantom limb pain among veteran amputees. Arch Phys Med Rehabil (2012) 1.39
Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum (2009) 1.37
Comparison of mail and telephone in assessing patient experiences in receiving care from medical group practices. Eval Health Prof (2005) 1.36
How do proxy responses and proxy-assisted responses differ from what Medicare beneficiaries might have reported about their health care? Health Serv Res (2008) 1.35
A comparison of three sets of criteria for determining the presence of differential item functioning using ordinal logistic regression. Qual Life Res (2007) 1.35
Differences in child versus parent reports of the child's health-related quality of life in children with epilepsy and healthy siblings. Value Health (2010) 1.32
The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol (2008) 1.29
Development and evaluation of the CAHPS hospital survey. Health Serv Res (2005) 1.29
Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia (2002) 1.29
Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care (2006) 1.27
Prospects and challenges in using patient-reported outcomes in clinical practice. Qual Life Res (2008) 1.26
Effect of CAHPS performance information on health plan choices by Iowa Medicaid beneficiaries. Med Care Res Rev (2002) 1.24
Evaluation of the Patient-Reported Outcomes Information System (PROMIS(®)) Spanish-language physical functioning items. Qual Life Res (2012) 1.23
Do health care ratings differ by race or ethnicity? Jt Comm J Qual Saf (2003) 1.23
The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res (Hoboken) (2011) 1.22
Racial differences in health-related quality of life among hemodialysis patients. Kidney Int (2004) 1.22
Norming plans for the NIH Toolbox. Neurology (2013) 1.20
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum (2007) 1.20
Disparities in HRQOL of cancer survivors and non-cancer managed care enrollees. Health Care Financ Rev (2008) 1.19
Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic. Value Health (2011) 1.19
The SF-36 physical and mental health factors were confirmed in cancer and HIV/AIDS patients. J Clin Epidemiol (2006) 1.19